However, the number of significant colorectal lesions and CRC that would be missed with this model is considerably lower than the number of missed lesions found when the FIT is applied alone, either at 2 or 10 μg Hb/g in faeces (Supplementary Table S4). The gene discussed is GSTM1; the disease is colorectal carcinoma.